Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jonathan Goldman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Ryan Sullivan - $3.72M in AVTX purchases and sales in the last 12 months
- Mittie Doyle - $2.98M in AVTX purchases and sales in the last 12 months
- Paul Varki - $1.51M in AVTX purchases and sales in the last 12 months
- Mitchell Chan - $72K in AVTX purchases and sales in the last 12 months
- Jennifer Riley - $52K in AVTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jonathan Goldman?
Jonathan Goldman is a corporate insider of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jonathan Goldman last file a Form 4?
The most recent primary Form 4 on record is dated 31 March 2026, one of 2 filings going back to 2025.
Has Jonathan Goldman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($163K) across all tracked filings.
